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THE IMPACT OF DIABETES MELLITUS ON LENGTH OF STAY AND MECHANICAL  




(Under the Direction of Dr. Rachel Culbreth) 
ABSTRACT 
Background: Diabetes Mellitus (DM) is a metabolic disease that affects the body’s ability to 
properly maintain accurate blood glucose levels, generally presenting as either Type I or Type II. 
DM has grown into a worldwide pandemic that has affected more than 422 million people, with 
35 million residing in the United States. This disease is one of the most chronic health issues in 
the United States with over $176 billion in medical cost, due to the long-term treatment it 
requires and complications that may arise. Diabetics have also been found to be at a 19 percent 
greater risk for motor vehicle accidents (MVA) than non-diabetics, influenced by several the risk 
factors associated with the disease. Not only has the driving capability of the diabetic population 
been found to be affected, but their ability to recover is of interest as well. 
Objective: The purpose of this study was to determine how DM may impact the length of stay 
and ventilator duration for MVA trauma patients at a Level-1 Trauma Center.  
Methods: Data was collected retrospectively among patients involved in motor vehicle accidents 
in intensive care at a major level-1 trauma center (n=2,802). Descriptive statistics were computed 
and Mann-Whitney U Tests, Chi-Square tests, and Independent Samples T-Tests were conducted 
to examine differences in diabetic patients and demographics, comorbidities, and patient 
outcomes (length of stay, ventilator days, and length of ICU stay).  
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Results: Among all the patients (n=2802), 8.8% were confirmed to have DM, and 92.7% were 
non-diabetic. Although the percentage of diabetic males was greater, there was no significant 
difference (p=0.179) between the number of males and females effected by DM. The mean age 
of diabetic patients and non-diabetic was found to be significant (p<0.001). The mean age for 
diabetic patients was 58.14 years in age and non-diabetic patients was 39.04 years in age. Race 
(p=0.380) was not significantly different, with 8.7% of diabetics in the African American 
population, 9.4% of Caucasians, and 6.8% of Asians. Total length of stay in the ICU (p=0.008) 
was significant with a median of 4 days for diabetic patients, and 3 days for non-diabetics. Total 
length of stay in the hospital (p=0.009) was significant as well, with a median of 10 days for 
diabetic patients and 7 days for non-diabetics. Total LOS on a mechanical ventilator (p=0.02) 
was also found to be statistically significant, with diabetic patients spending a higher number of 
days on the ventilator compared to non-diabetic patients.  
Conclusion: MVA patients with Diabetes Mellitus may require additional interventions during 
their ICU and hospital stay in or to address and manage the challenges presented by the disease. 
The diabetic population presents with higher rates of wound infection, UTI, pneumonia, cardiac 
arrest, MI, ARDS, as well as unplanned intubations. Patients with DM are more likely to develop 
any complication following a traumatic event over patients without. Since the average age for 
diabetic patients is almost 60 years, people tend to develop multiple comorbidities such as 
obesity and other health issues. This may exacerbate their DM and make it difficult to properly 
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Diabetes Mellitus (DM) is a chronic metabolic disease that negatively impacts the body’s 
ability to maintain accurate blood glucose levels. The two most common forms of DM consist of 
Type I and Type II. Type I DM is characterized by poorly functioning or damaged pancreatic 
cells, with onset of symptoms more commonly occurring in childhood or adolescence, but not 
excluding adulthood.1,2 Patients with Type I DM require the administration of exogenous insulin 
through injection or insulin pump in order to sustain life. Type II DM is generally developed 
later in adulthood due to the prevalence of obesity and other comorbidities that cause cells to 
become resistant to the hormonal function of insulin. Excess body fat accumulation is the leading 
cause for the formation and multiplication of insulin resistant cells throughout the body.2,3 
 Although Type II DM comprises about 90% of diabetes cases, it is considered to be less 
detrimental than Type I DM due to its preventable nature.4 Modifiable risk factors for Type II 
DM include obesity/overweight, physical inactivity, smoking, hypertension, and abnormal 
cholesterol levels; all which can be controlled or reversed by practicing healthy lifestyle 
choices.5 However, there are several non-modifiable factors such as family history, race/ethnic 
background, age, and history of gestational diabetes, that may increase a person’s risk to 
developing prediabetes, ultimately leading to Type II DM.4,5  
DM has grown into a worldwide pandemic that has plagued more than 422 million people 
globally, with 34.2 million residing in the United States in 2018.6 In the state of Georgia alone, 
every 1 in 10 adults have been diagnosed with DM, resulting to over 1 million confirmed cases, 
and impacting over 12.1% of the adult population.7 CDC data from 2017 indicates the treatment 
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of DM resulted in over 16 million hospital visits, which contributed to $376 billion in nationwide 
medical cost; $237 billion in direct medical cost and $90 billion in reduced productivity in the 
workplace.6 The extravagant cost is a product of long-term treatment plans that consist of 
inpatient hospital care, prescription medication, physician office visits, anti-diabetic agents, and 
complications that may arise due to the exacerbation of uncontrolled DM.8 
Of the millions of people living with DM in the United States, a majority will seek or 
currently hold a driver license. Persons with DM have been found to be at greater risk for motor 
vehicle accidents (MVA) than non-diabetics.9 However, a majority of previous MVA studies on 
the diabetic population specifically focused on those who were “insulin-treated” or had Type I 
DM, due to the greater prevalence of hypoglycemic events. 9,10 This population is more prone to 
suffer debilitating neurological effects that impair driving capability. 10,11 When a driver 
experiences a hypoglycemic event, driving performance, reaction time, and hand eye 
coordination start to deteriorate.10 A hypoglycemic event may lead to lightheadedness or black 
out spells, which can directly cause an MVA if the person is actively driving.10  
Not only is the driving capability of the diabetic population under surveillance, but their 
ability to recover from an MVA is of interest as well. Previous data indicated that diabetics have 
an increased hospital length of stay (LOS) when admitted for any medical procedure, no matter 
the type.8 When observing diabetics the days following an elective surgery, they experienced a 
mean hospital LOS of 9.08 days compared to 4.76 days for non-diabetic patients, resulting in a 
mean cost increase of nearly $4,000 for the diabetic patients.12 The occurrence of death, 
myocardial infarction, pneumonia, and acute kidney injury were also found to be significantly 
increased in the sample of diabetic patients.12,13 The presence of DM has a strong association 
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with increased risk for developing further complications, which may lead to multiple intubations 
or readmissions.8,13 
Statement of the Problem 
Little research exists pertaining to the analysis of how motor vehicle accidents may 
specifically impact injury severity and recovery experienced by patients presenting with Diabetes 
Mellitus.  A majority of previous studies assessing number of ICU days, number of days spent on 
a mechanical ventilator, as well as hospital LOS and total hospital cost of diabetic patients are 
not associated with motor vehicle trauma, but more so focus on post-operative care, as well the 
management of other issues such as hypoglycemic events, diabetic ketoacidosis, hyperglycemia, 
and respiratory distress. Although these studies are helpful in determining the best treatment plan 
for diabetic patients, the type of injuries acquired during an MVA may require different 
approaches to patient care.  
Data involving MVA trauma was highly concentrated on the presence of obesity, and its 
impact on patient injury severity level as well as injury location.14,15 Various analysis techniques 
are needed to determine if non-diabetics, Type I diabetics, and Type II diabetics, will each 
experience a different severity of injuries and time to recovery. This may directly impact hospital 
length of stay and time spent on a ventilator based on their diabetic classification. Although there 
is substantial amount of literature on the effect of DM on driving capability, further research is 
needed to determine if DM actually has an impact on recovery from MVA trauma over patients 
who are non-diabetic. Therefor due to a lack of supportive research, it is unclear if Type I and 
Type II DM truly has a significant impact on hospital length of stay and duration on mechanical 
ventilation following a motor vehicle accident.  
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Purpose of the Study 
 The purpose of this study is to determine how Diabetes Mellitus may impact hospital 
length of stay, ICU length of stay, and ventilator duration, for motor vehicle trauma patients at a 
Level-1 Trauma Center.  
Research Questions 
1. What is the prevalence of diabetes among patients involved in motor vehicle accidents in 
a level-1 trauma center? 
2. Are there differences in length of stay between diabetic and non-diabetic patients 
involved in motor vehicle accidents? 
3. Are there differences in mechanical ventilation duration between diabetic and non-
diabetic patients involved in motor vehicle accidents? 
4. What is the prevalence of diabetic patients involved in motor vehicle accidents that also 
have other comorbidities?  
Definition of Terms 
Cellular Respiration: Metabolic reactions and processes that take place in the cells of 
organisms to convert chemical energy from oxygen molecules or nutrients into adenosine 
triphosphate (ATP), and then release waste products.  
CDC: The United States Centers for Disease Control and Prevention is the national 
public health agency of the United States.  
Diabetic Ketoacidosis: Diabetic ketoacidosis is a serious complication of diabetes that 
occurs when your body produces high levels of blood acids called ketones. The condition 
develops when your body can't produce enough insulin. Insulin normally plays a key role 
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in helping glucose, a major source of energy for your muscles and other tissues, enter 
your cells. 
Diabetes Mellitus: A condition defined by persistently high levels of blood (glucose) in 
the blood. The two most common are Type I and Type II diabetes. 
Exogenous Insulin: Any insulin that your body doesn’t make on its own, that you 
receive via injection, insulin pump, or most recently by inhalation device.  
Glucose: A Simple sugar which is an important energy source in living organisms and is 
a component of many carbohydrates. It is primary source of energy produced from 
digesting carbohydrates into a chemical that the body can easily convert to energy 
GLUT-4 Vesicles: An insulin-regulated glucose transporter that is responsible for 
insulin-regulated glucose uptake into fat and muscle cells.  
Dysglycemia: A nonspecific term for any alteration in serum glucose that encompasses 
both hypoglycemia and hyperglycemia. 
Insulin: A peptide hormone produced by beta cells of the pancreatic islets; it is 
considered to be the main anabolic hormone of the body. It regulates the metabolism of 
carbohydrates, fats and protein by promoting the absorption of glucose from the blood 
into liver, fat and skeletal muscle cells.  
Insulin Resistant: In states of insulin resistance, the same amount of insulin does not 
have the same effect on glucose transport and blood sugar levels. Risk factors for insulin 
resistance include obesity, sedentary lifestyle, family history of diabetes, various health 
conditions, and certain medications. Insulin resistance is considered a component of 
the metabolic syndrome  
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Islet of Langerhans: The pancreatic islets or islets of Langerhans are the regions of the 
pancreas that contain its endocrine (hormone-producing) cells, discovered in 1869 by 
German pathological anatomist Paul Langerhans.  
LOS: Medical abbreviation for Length of Stay 
MVA: Motor Vehicle Accidents involving an automobile, motorcycle, motor scooter, or 
all-terrain vehicle 
Pancreatic β-cells: β cells are a type of cell found in pancreatic islets that synthesize and 
secrete insulin and amylin. Beta cells make up 50–70% of the cells in human islets. In 
patients with Type 1 diabetes, beta-cell mass and function are diminished, leading to 
insufficient insulin secretion and hyperglycemia. 
Hypotheses 
1. Motor vehicle accident trauma patients with Diabetes Mellitus will experience a greater 
length of stay in the ICU, greater amount of time on a mechanical ventilator, as well as an 
increased total length of stay in the hospital than non-diabetic patients. 
2. The mean age of diabetic patients in the ICU will be higher than that of non-diabetic 
patients 
3. Males will account for a greater percentage of diabetic patients in the ICU than women 
4. African Americans will account for a greater percentage of diabetic patients in the ICU 
than any other race/ethnic group 
Assumptions 
1. All of the patients in this study have the correct diagnoses for diabetes mellitus and other 
comorbidities.  
2. All of the patients admitted to the intensive care unit are documented in this thesis.  
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Significance of the Study 
In the United States motor vehicle accidents are a leading cause of death and injuries that 
require hospitalization. With DM being one of the most common chronic diseases, millions of 
those afflicted are required to transport themselves daily via motor vehicle.9 As the prevalence of 
diagnosed diabetes and pre diabetes continues to rise, it is of great importance that healthcare 
practitioners understand how DM may impact patient recovery, as well as be able to provide 
optimal treatment following an MVA. For diabetic patients, as hospital LOS increases, more 
diabetes related complications begin to arise, leading to increased hospitalizations, and possibly 
leading to a decline in quality of life. Motor vehicle accident diabetic patients in the ICU present 
a unique problem of requiring acute emergency care while also requiring management of a 



















DM is a chronic health condition that effects the manner in which the pancreas regulates 
and releases insulin, in order to properly transfer sugar, or glucose, into the body’s cells. 2,4,16 As 
the body consumes food, it is broken down by acid and enzymes in the stomach and small 
intestine and transformed into glucose, which is then absorbed into the bloodstream. As blood 
glucose levels become elevated, metabolic signals trigger pancreatic β-cell receptors on the islet 
of Langerhans to release insulin into the blood.3,4 Insulin is found to be the only hormone in the 
human body capable of binding to cell receptors that stimulate GLUT-4 vesicles to migrate to the 
surface of the cell.3,4 Once the vesicles reach the surface, they penetrate through the cell 
membrane and allow the passage of glucose. From there, the process of cellular respiration is 
initiated to manipulate glucose into ATP.  
Type I Diabetes Mellitus 
When the manufacturing of insulin and the exocrine functions of pancreatic β-cells are 
adulterated, the formation of Type I DM will persist.16 Type I DM is caused by gene 
abnormalities and environmental factors, such as viruses, that provoke an autoimmune response 
that attack and destroy insulin producing β-cells.1,3 Damage to β-cells causes metabolic glucose 
signaling to become an incomplete pathway and restricts the body from producing any insulin or 
only producing a minimal amount. Type I DM rapidly progresses within a few weeks to a few 
months after initial onset.1,2 Due to the development of the disease in childhood and adolescence, 
it is often referred to as juvenile diabetes. Another name given to Type I DM is insulin dependent 
diabetes based on the required injection of exogenous insulin.3.12 Although the widely accepted 
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name for Type I DM is juvenile diabetes, the onset may occur at any age.18 When onset occurs 
well into maturity, it is regularly initially misdiagnosed as Type II DM until further testing 
ensues.1,18 
Diabetic Ketoacidosis 
Individuals experiencing a Type I diabetic event exhibit signs and symptoms of polyuria, 
polydipsia, weight loss, nausea/vomiting, excessive tiredness and diabetic ketoacidosis 
(DKA).1,17  DKA is a life-threatening symptom of both Type I and Type II DM that is capable of 
inducing a diabetic coma or death.17,19 The process of DKA occurs when the body experiences 
low insulin levels and glucose is prohibited from transferring across the cell membrane.17,19 If 
cells cannot participate in the uptake of glucose to manufacture energy, liver enzymes begin to 
break down fat, leading to the release of acidic ketones into circulation. When a rapid surge of 
ketones enters the bloodstream a dangerous decrease in blood pH can occur. 17,19 
Type II Diabetes Mellitus 
Type II DM develops from two main mechanisms of action. First, the production of 
insulin deteriorates over time leading to an insufficient amount of insulin in the blood to properly 
maintain homeostatic blood glucose levels.2,8 Although low to non-existent insulin is 
characteristic of Type I DM, the decrease in available insulin in Type II DM is a result of 
genetics and poor lifestyle choices, and not autoimmune destruction of pancreatic β-cells.2,3 
Secondly, as insulin receptors on the cell membrane grow increasingly resistant and less 
sensitive to the binding of insulin, the body’s cells lose the ability to utilize the hormone. Insulin 
resistance is believed to develop from the onset of inflammatory responses throughout the body.3 
Recent literature suggest the presence of adipose tissue and chronic inflammation promoted the 
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body’s production of various cytokines, that are linked to disruption of the insulin signaling 
pathway. 3 When this pathway is damaged, glucose is again restricted from entering the cell. 
Global Prevalence 
The presence of DM is becoming the world’s fastest growing chronic disease, and one of 
the most prevalent issues burdening available healthcare resources and medical cost in every 
inhabited country in the world.20,21 The top 10 countries with the largest diabetic populations 
include from greatest to least, include China, India, United States, Pakistan, Brazil, Mexico, 
Indonesia, Germany, Egypt, Bangladesh.20,21 
The International Diabetes Federation (IDF) estimated that since 2017, children and 
adolescents less than 15 years of age, have contributed to an increase of nearly100,000 novel 
Type I DM cases each year.21 As of 2019, a total of 463 million adults were estimated to be 
living with DM, representing 9.3% of the global adult population, age 20–79 years old. This 
number is predicted to increase to 578 million (10.2%) in 2030, and 700 million (10.9%) in 
2045.20,21 As age increases, the prevalence of DM increases as well. Adults ages 65-79 years old 
account for more than 111.2 million (19.9%) of the global diabetic population.21 
Prevalence Within the United States 
The CDC’s National Diabetes Statistics Report: 2020, presented data collected in the 
United States from 2017 and 2018, including all adults age 18 years and older. The report 
provided detailed feedback on the allocation of DM within the country. In 2018, 34.2 million 
(10.5%) adults had a confirmed diagnosis of either Type I or Type II DM. 88 million (34.5%) 
adults were diagnosed with prediabetes, and 7.3 million adults had not reported or had not 
known their diabetic status.6 Diabetes remains a relevant issue in all race/ethnic populations 
residing in the US, currently impacting 14.7% of Native Americans/Alaskan Natives, 12.5% of 
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Hispanics, 11.7% of African Americans at, 9.2% Asians, and 7.5% of Caucasians.6 DM was 
found to be the 7th leading cause of death in adults aged 50 years and older with 83.1 diabetic 
related deaths per 100,000 death certificates examined.6 Diabetics are also predicted to die 4.6 
years earlier, develop disabilities 6 to 7 years earlier, and spend about 1 to 2 more years in a 
disabled state than adults without diabetes.6,20 
Prevalence Based on Gender 
Diabetes is more prevalent in the male population, afflicting 9.6% of all males worldwide 
in contrast to 9.0% of all females (Figure 1).21 CDC data from 2017 indicated that a higher 




Due to men being more biologically predisposed to the development of DM, male age 
becomes a risk factor once they reach 40 years of age. While female age does not become a risk 
factor until they reach 45 years of age.6,21 The difference in disease progression between the 
sexes is more strongly correlated to the accumulation of visceral body fat and less associated 
Figure 1. Worldwide diabetes prevalence by gender and age 
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with BMI, as was once believed.21,22 The development of body fat related health issues in men is 
faster to develop at a lesser percentage of fat accumulation than women.22 Therefore, women can 
experience a greater fluctuation in body fat before they start to develop obesity/overweight 
related health issues when compared to their male counterpart.21  
Diabetes Mellitus Impact on Driving Capability 
 With millions of cars on the road in today’s world, the driving capability of diabetic 
patients has been greatly studied to determine if complications associated with DM (including 
hypoglycemia, double vision, or altered mental status) are a contributing factor to the occurrence 
of motor vehicle accidents.23 It has been indicated that the hypoglycemic events that diabetics 
may experience is the leading cause to the increased incidences of MVA in this population.23  
When an unsuspecting driving starts to experience a hypoglycemic event, all skills associated 
with driving start to deteriorate including driving performance, reaction time, decision making, 
and hand eye coordination.23,24  Because of these debilitating effects that occur at such a sudden 
onset, the American Diabetes Association urges drivers to disclose their diabetic status and 
receive further evaluation for driving capability.23 
 Hypoglycemic events are never planned; therefore, diabetics must have sufficient control 
in managing their disease. A previous study tested the driving capacity of 480 diabetic drivers. A 
total 102 (25%) of the drivers experienced a hypoglycemic event while driving.23,24,28 The main 
characteristics of participants that experienced an event while driving wear less than 60 years of 
age and had DM for less than 15 years.23 When the investigators recanted patient interviews, they 
discovered only 23.5% of participants discussed the risk of driving as a diabetic with a health 
care practitioner.23 The study suggested that if more diabetics would seek help and knowledge 
with managing their disease, MVA due to hypoglycemia would decrease.23,24 
Running Head: Impact of DM on Length of Stay 
24 
 
 A virtual driving simulation study discovered that even if a diabetic person is not actively 
experiencing a hypoglycemic event, they still presented with slower foot transfer to brake time 
and slower brake time period.25 Diabetics also experienced faster times to collisions struggling to 
avoid objects such as trees, buildings, signs, and other cars.24,25 The research indicated that 
normoglycemic diabetics presented with a decline in cognitive function, slower reaction times, 
and lack of pedal control, which all lead to poor outcomes in driving situations.25 
 Diabetes can lead to many problems including nerve damage to the lower extremities of a 
patient’s body.25,26,27 This may cause the development of an insensate plantar foot, pedal 
ulcerations, soft tissue and bone infection, and limb amputation.26 The research suggest that all 
of these issues lead to impairment of diabetic driving. Limb amputation was specifically looked 
at in driver ability.25 Although limb amputation may affect return to driving it, it showed 
beneficial results in delayed response time. It was observed that many older amputees were not 
returning to driving after surgery depending on the body part amputated.25 However, driving 
ability was only assessed after amputation and not before in these particular patients. The data 
indicated that drivers with lower extremity sensory neuropathy does lead to slower brake 
response times with abnormally long brake reactions compared to drivers without diabetes or 
lower extremity neuropathy.25,27,28 A 2015 study found that 28% of MVA rear end cases were a 
result of delayed response time.25 When comparing drivers with diabetes to those without, there 
was a 36% higher chance of diabetic drivers experiencing an MVA.25,28 The research concluded 
that lower extremity neuropathy is one of the main causes of delayed reaction time and more 
research is needed to continue and test this finding.25,26,27,28 
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Impact of DM Related Comorbidities/Complications on Hospital Cost and LOS 
DM has become a steadily growing economic vacuum due to the large proportion of 
healthcare costs allocated to long term treatment plans needed to properly manage the disease.29 
The development of DM and related comorbidities also increase the time and cost spent treating 
this population.29,30 A past analysis that evaluated data from a 2008 Healthcare Cost Utilization 
Project, discovered that diabetics experience increased hospital LOS when admitted for any 
medical procedure, non-specific to the type.12,29,30 Diabetics were studied during the days 
following an elective surgery, are were observed to experience a mean hospital LOS of 9.08 
days, while non-diabetic patients experienced a mean of 4.76 days.12 The mean hospital cost for 
DM patients was $19,547, with only $15,873 for non-diabetics, nearly a $4,000 difference.12 The 
occurrence of death (1.42% vs 0.93%), myocardial infarction (1.6% vs 0.59%), pneumonia 
(2.88% vs 0.32%), and acute kidney injury (11.2% vs 2.53%), were all significantly increased for 
diabetic patients.12,31 The study concluded that diabetic patients experience significantly 
increased rates of DM related complications and that result in the accumulation of greater 
hospital cost.12,30,31 
A recent retrospective database analysis performed in 2019, reviewed a longitudinal 
cohort of DM patients based in Taiwan in 2012.30 The authors identified and examined 11 DM 
related comorbidities and complications including ulcers, amputation, blindness, end-stage renal 
disease (ESRD), congestive heart failure (CHF), fatal ischemic heart disease (IHD), nonfatal 
IHD, fatal myocardial infarction (MI), nonfatal MI, fatal stroke, and nonfatal stroke. For each 
hospitalization, the authors reported on length of stay, total costs of hospitalization, and inpatient 
drug costs.29,30 The sample included 27, 473 DM patients who incurred a total of 29, 582 diabetic 
related hospitalizations over the course of the study.30  
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The data indicated that more men (62.5%) than women (37.5%) were hospitalized due to 
a related complication of DM.30 About 93% of the patients experienced at least one 
complication-related hospitalization, with the most prevalent being nonfatal stroke (34.7%), 
nonfatal IHD (28.7%), CHF (14.4%), and ESRD (13.9%).30 Amputation required the longest 
LOS with a mean of 21.4 days, followed by non-fatal stroke (13.36 days), and ulcers (12.7 days). 
The greatest hospital cost reported was the treatment of non-fatal ischemic heart disease, 
equaling $10, 761 USD after converting from the Taiwanese dollar.30 When comparing the cost 
of this treatment to that of the elected surgeries in the previous study, it is understood that 
medical procedures overseas is less expensive than surgery in the US due to the high cost of 
healthcare experienced in this country.  
A second Taiwanese study conducted in 2014, shared similar results, reporting that total 
medical costs, hospitalization costs, and risk of hospitalization all significantly increased with the 
number and severity of diabetes related comorbidities and complications.30  Additionally, a 2016 
Chinese study specifically indicated that prescription drugs and laboratory tests were the two 
most expensive factors that increased hospitalization costs for diabetics patients.30 The authors 
suggested that the hospitalization cost of one complication related event, could easily surpass the 
yearly healthcare cost of a diabetic patient with no complications or additional comorbidities.30  
ICU Stay and Mechanical Ventilation in Diabetic Patients  
 
 The management of diabetic patients in the ICU has remained a persistent problem for 
healthcare professionals for the last 20 years.32 Dysglycemia, a term that encompasses both 
hypoglycemia and hyperglycemia, during an ICU stay, has been correlated with increased 
prevalence of hospital complications and mortality among the diabetic population.32,33 
Development of recent clinical practices promotes the use moderate glucose control, to maintain 
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levels around 140 mg/dl.32 Previous practices suggested utilizing tight control, keeping glucose 
levels between 80 to110 mg/dl.32 Tight glucose control stemmed from lack of available 
knowledge as well as the absence of technology that now allows for the continual or rapid 
monitoring of glucose levels in the ICU.32,33 Before hospitals were able to perform instant 
glucose monitoring, fear of causing a medically induced hyperglycemic event may have caused 
patients to experience poorly maintained glucose levels.  
 A recent meta-analysis of 141 studies by Siegelaar et al. indicated that purely having a 
diagnosis of diabetes in the ICU does not directly lead to increased mortality, until the addition 
of other risk factors is incorporated.31,32,34 Diabetes leads to a higher incidence of nearly all 
comorbidities including renal, cardiovascular, and neuropathic disease.31,32 The onset of diabetic 
complications can directly impact mortality rates of critically ill patients. A prevalent risk factor 
of mortality in diabetic patients was the development of ICU bloodstream infections.31,32 
However, the most significant predictor of mortality was the initiation of mechanical 
ventilation.32 Mechanical ventilation is believed to play a role in the poor glycemic control of 
diabetic patients in the ICU, due to the continuous tube feeding that must occur while a patient is 
intubated. 32,34 Daily nutrition regimens are utilized to ensure that patients are not being be 
overfeed, but the administration of a liquid diet directly into the stomach increases 
gastrointestinal absorption.32 This mechanism causes blood glucose levels to elevate more 
rapidly than the traditional eating and digesting process.33,34 If the mechanically ventilated 
diabetic patient has impaired glucose function, a hyperglycemic event can ensue.33 The use of 
propofol for sedation is also associated elevated blood glucose levels due to the caloric and lipid 
content of the drug.32 Severe hyper glycemia was also found to be more prevalent in diabetics 
receiving post-operative care in the ICU, as opposed to care for a medical illness.32,34 The 
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greatest severity of issues was observed in cardiac surgery patients due to the traumatic impact of 
open chest surgery on the body.31,32,33 Any traumatic event, whether it was planned or unplanned 
caused diabetic patients to experience higher rates of wound infection, UTI, pneumonia, cardiac 
arrest, MI, ARDS, and emergency intubations during their stay in the hospital.31,32 Increased 
mortality in diabetic patients in the ICU is observed to is a multifactorial issue that is affected by 























The research questions for this study are as follows:  
1. What is the prevalence of diabetes among patients involved in motor vehicle accidents in 
a Level-1 trauma center? 
2. Are there differences in length of stay between diabetic and non-diabetic patients 
involved in motor vehicle accidents? 
3. Are there differences in mechanical ventilation duration between diabetic and non-
diabetic patients involved in motor vehicle accidents? 
4. What is the prevalence of diabetic patients involved in motor vehicle accidents that also 
have other comorbidities?  
Data was collected at a level-one trauma center located in Atlanta, GA (n = 2802). This 
sample size was inclusive of all patients who were intubated and mechanically ventilated and 
admitted into the intensive care unit (ICU) in this trauma center following a motor vehicle 
accident between January 2011 and September 2015. The trauma center is part of a 623-bed 
public hospital. This retrospective study was approved by the university institutional review 
board. The requirement for informed consent was waived due to data being previously 
obtained from records of former patients who were discharged from the hospital prior to this 
study. All identifying factors were removed from patient records. Furthermore, all ethical 
considerations for this study are in accordance with the World Medical Association 
Declaration of Helsinki.   
 All the patients in this study were either directly admitted to the ICU or admitted 
following surgery. Patients in this analysis were admitted between January 2011 and 
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September 2015. In the current study, motor vehicle accident (MVA) is defined as any 
collision involving an automobile, motorcycle, motor scooter, or all-terrain vehicle. Patients 
were identified using a trauma registry, a database containing demographic, injury and 
outcome information from the scene of the accident through hospital discharge. Patient 
characteristics by diabetic classification is presented in Table1.  Medical records were 
searched and compiled into a deidentified dataset for analysis. Patient age, sex, height, 
weight, injury severity, time on mechanical ventilation, and whether the patient lived or died 
were collected from the trauma registry, and electronic medical records. Injury severity was 
assessed using the standard injury severity score (ISS).  
Statistical Analysis  
Subgroup analyses were conducted on the following: diabetic vs. non diabetics, and male 
vs. female. Independent samples t-tests were conducted to determine whether statistically 
significant differences were present in all included parameters between diabetic and non-
diabetics patients. Mann Whitney-U tests were used to determine median LOS in the ICU, LOS 
in the hospital, number of days on a ventilator, number of comorbidities, as well as number of 
complications experienced. Chi-Square tests were utilized to assess the prevalence of diabetes 
within gender groups, as well as within the various race/ethnic groups including African 
Americans, Caucasian, and Asian/other patients. All statistical analysis of the data was 
conducted using the Statistical Package for Social Science software (version 25.0, SPSS Inc. 









The research questions for this study are as follows:  
1. What is the prevalence of diabetes among patients involved in motor vehicle accidents in 
a level-1 trauma center? 
2. Are there differences in length of stay between diabetic and non-diabetic patients 
involved in motor vehicle accidents? 
3. Are there differences in mechanical ventilation duration between diabetic and non-
diabetic patients involved in motor vehicle accidents? 
What is the prevalence of diabetic patients involved in motor vehicle accidents that also 
have other comorbidities? 
 A total of 2802 patients were recorded in the motor vehicle accident registry of a Level-1 
trauma center (Table 1). Over the course of the study, the hospital treated (50.0 ± 9.7) vehicular 
accident patients per month. Among all the 2802 patients included in the sample, 247 (8.8%) 
were confirmed to have Diabetes Mellitus (DM). The remaining 2,555 (91.2%) of patients were 
absent of DM. Of the 247 diabetic patients, women account for 73 (29.5%) of DM patients, and 
men accounted 174 (70%) of diabetic patients. Men amounted to 1,866 (66.6%) of the total 
number of patients, while women made up 936 (33.4%) of the total sample. In this particular 
sample, men substantially outnumbered the women, leading to a higher prevalence of diabetes 
within male sub-group. Out of the 936 women included, 73 (7.8%) had DM, compared to the 863 
(92.2%) of women who did not present with diabetes. Out of the 1,866 male participants, 174 
(9.9%) had diabetes mellitus, and 1672 (90.1%) of men did not have DM. Although the 
Running Head: Impact of DM on Length of Stay 
32 
 
prevalence of diabetic males was greater, there was no significant difference (p=0.179) between 
the number of males and females effected by DM.  
 
Table 1. Patient Characteristics by Diabetic Classification 









    Female 











1.805, (1), p=0.179 
Age, Mean (SD)b 39.04 (17.08) 58.14 (14.45) 40.73 (17.71) -19.50, (316), 
p<0.001 
Racea 
   African-American 
   Caucasian 














1.94, (2), p=0.380 
Ethnicitya 
    Non-Hispanic 











1.19, (1), p=0.275 
Total LOS in ICU 
Median (IQR)c 
3 (5) 4 (6) 3 (5) P=0.008 
Total LOS in hospital 
Median (IQR)c 
7 (13) 10 (15) 7 (13) P=0.009 
Total length on ventilator 
Median (IQR)c 
0 (3) 0 (3) 0 (3) P=0.020 
Number of comorbidities, 
Median (IQR)c 
0 (1) 2 (1) 1 (1) P<0.001 
Number of complications, 
Median (IQR)c 
0 (0) 0 (1) 0 (0) P=0.215 
Injury severity score (ISS), 
Mean (SD)b 
18.17 (11.71) 15.04 (9.46) 17.89 (11.56) 4.85, (324), p<0.001 
a= Chi-Square test; b=Independent samples t-test; c=Mann-Whitney U Test 
 
The mean age difference of non-diabetic and diabetic patients was found to be 
statistically significant (p<0.001). The mean age of the total population sample was (40.73 ± 
17.71) years. The mean age for the diabetic patients was 58.14 ± 14.45 years, and the mean age 
for nondiabetic patients was nearly half of the diabetic patients at 39.04 ±17.08. Race (p=0.380) 
was indicated to be not significantly different. Out of a total of 2802 MVA, patients African 
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Americans made up the majority the total sample population representing 1423 (50.8%) of 
patients. Caucasians accounted for 1113 (39.7%) of patients and Asians/other only accounted for 
266 (9.5%) of patients. Within the group of the 1,423 African Americans, 124 (8.7%) had 
diabetes mellitus. Out of 1113 Caucasians, 105 (9.4%) were diabetic patients. Although African 
Americans made up a majority of the patient population, Caucasians still had a higher prevalence 
of diabetes within their sub-group. Out of the 266 Asian/Other patient, only 18 (6.8%) were 
confirmed to have DM.  
When comparing the number of diabetic patients by race/ethnic group to the total number 
of diabetic cases (n=247), African Americans amounted to nearly 50.2% of the diabetic patients. 
Caucasians accounted for 42.5% of the diabetic patients and Asians accounted for only 7% of 
diabetic patients. Out of 2802, 143 patients associated with Hispanic descent making up (5.1%) 
of the patient population. Out of the 247 diabetic cases only 9 Hispanic relating patients had 
diabetes, accounting for 3.6%. Total length of stay in the ICU (p=0.008) did show to be 
statistically significant between diabetics and non-diabetics patients. Diabetic patient’s median 
amount was 4 days (Figure 2) in the ICU compared to 3 days (Figure 3) for that of non-diabetics. 
Total length of stay in the hospital (p=0.009) was statistically significant as well, with a median 
of 10 days for diabetic patients and 7 days for non-diabetics. Total length of stay on a mechanical 
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ventilator (p=0.02) was also found to be statistically significant, with diabetic patients spending a 










Figure 3. Number of total ventilator days for non-diabetics 
Figure 2. Number of total ventilator days for diabetics 
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Note. 0 indicates non-diabetic patients and 1 indicates diabetic patients.  
 
The presence of comorbidities between diabetic and non-diabetic patients was 
statistically significantly (p<0.001) with diabetic patients experiencing a median of 2 
comorbidities but patients without diabetes did not indicate any. The number of complications 
experienced in diabetics versus non diabetics was found to have no statistical significance 
difference (p=0.215). Injury severity score was found to be statistically significant (p < 0.001) 
with diabetes reporting a mean of (15.04 ±9.46), and non-diabetic patients reporting a mean of 
(18.17 ± 11.71). The ISS for the total population both diabetics and non-diabetics combined was 
(17.89 ± 11.56). According to the Injury Severity Scale, patients without diabetes had a 
“moderate” score between (9-15) while those without diabetes had a “serious” score between 
(16-24). 
 
Figure 4. Number of total ventilator days for non-diabetics compared to diabetics 





 In the current study there was a statistically significant relationship found between the 
presence of diabetes mellitus and total length of stay on the ventilator, total length of stay in the 
intensive care unit, and total length of stay in the hospital. Diabetes is a chronic disease that in 
itself requires strict lifetime management in order to maintain a sufficient quality of life. It 
requires daily monitoring in order to restrain the many complications that may arise if the disease 
becomes uncontrolled. However, when a diabetic patient experiences bodily trauma, such as that 
of a motor vehicle accident, maintenance becomes more difficult and other complications more 
easily arise. Studies suggest that management of diabetes in the ICU is critical for patients who 
have just experienced a traumatic event due to the many complications that diabetic patients are 
more suspectable to.31,32  
 Because of this, the diabetic trauma patients experienced significantly increased amount 
of time hospitalized due to the management of their disease, the injuries that they may have 
incurred, as well as treatment of the onset of other diabetes related complications. An analysis 
that evaluated data from a 2008 Healthcare Cost Utilization Project, discovered that diabetics 
experience increased hospital LOS when admitted for any medical procedure. It was indicated 
that diabetic related issues could arise increase the time and cost allocated to a patient. A 
Taiwanese study conducted in 2014, shared similar results, reporting that total medical costs, 
hospitalization costs, and hospitalizations all significantly increased with the number and 
severity of diabetes related comorbidities and complications.30 A recent meta-analysis, indicated 
that purely having a diagnosis of diabetes in the ICU does not directly lead to increased 
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complications and increased hospitalization, until the addition of other risk factors is 
incorporated.31,32,34   
Limitations 
 The results of this study should not be interpreted as all-inclusive of critical patients in 
every ICU due to varying locations demographics. This study was a retrospective study design 
and may lead to misrepresentation of true associations. This study was also limited by the 
variables that were reported and made available in the trauma registry. All the data in the study 
from trauma patients and should be used with caution when comparing the noncritical patient 
population. Lastly, the prevalence of diabetes varies greatly around the nation and the world, 
making results difficult to generalize in other regions and countries. 
Conclusion 
 This study found that motor vehicle trauma patients with diabetes mellitus were reported 
to have significantly more days on a ventilator, spent more time in the ICU, as well as more total 
days in the hospital. Diabetic patients require additional interventions during their ICU and 
hospital stay in order to address and manage the challenges presented by the disease. Patients 
with DM are more likely to develop any complication following a traumatic event over patients 
without. While in the ICU, the diabetic population presents with higher rates of wound infection, 
UTI, pneumonia, cardiac arrest, MI, ARDS, as well as unplanned intubations. Since the average 
age for diabetic patients is nearly 60 years, the development of multiple comorbidities such as 
obesity and various health issues is likely to occur. This may cause diabetic related 
complications to manifest, increasing patient mortality and making it difficult to properly 
maintain, especially following a traumatic event such as a motor vehicle accident. 
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